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Drugs those are given as solid dosage form and having low solubility often have a lack of flexibility in drug 
formulation and administration. The dissolution rate could be the rate-limiting process in the absorption of a 
drug from a solid dosage form of relatively insoluble drugs. Solid dispersion technologies are promising 
techniques for improving the water solubility, and hence dissolution and bioavailability of hydrophobic 
drugs. It is done for Biopharmaceutical Classification System (BCS) II Class drugs. Solid dispersion is the 
dispersion of one or more active ingredients in hydrophilic inert carrier matrix at molecular level. Solid 
dispersions of poorly water-soluble drugs with water-soluble carriers have been reduced the incidence of 
these problems and enhanced dissolution. The focus of this review article is on advantages, disadvantages 
and the method of preparation, and characterization of the solid dispersion. This review also discusses the 
recent advances in the field of solid dispersion technology. 
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INTRODUCTION 
The enhancements of oral bioavailability of poorly 
water-soluble drugs often show poor bioavailability 
because of low and erratic levels of absorption.[1] Oral 
bioavailability of drugs depends on its solubility and/or 
dissolution rate, therefore major problems associated 
with the drugs is its very low solubility in biological 
fluids, which results into poor bioavailability after oral 
administration [2]. Therapeutic effectiveness of a drug 
depends upon the bioavailability and ultimately upon 
the solubility of drug molecules. Solubility behavior of 
a drug is one of the key determinants of its oral 
bioavailability. In recent years, the number of poorly 
soluble drug candidates has increased tremendously. 
The formulation of poorly soluble drugs for oral 
delivery presents a challenge to the scientist. So the 
pharmaceutical researcher‟s focuses on two areas for 
improving the oral bioavailability of drugs that includes, 
enhancing solubility and dissolution rate of poorly 
water-soluble drugs, and enhancing permeability of 
poorly permeable drugs. It has been estimated that 40% 
of new chemical entities currently being discovered are 
poorly water soluble. Therefore lots of efforts have been 
made to increase dissolution of drug. Methods available 
to improve solubility include salt formation, 
micronization and addition of solvent or surface active 
agents, nanosuspension, microemulsion, modification of 
crystal habits, self micro emulsifying drug delivery 
system and solid dispersion etc.  
Solid dispersion (SD) is one of such methods and 
involves a dispersion of one or more active ingredients 
in an inert carrier or matrix in solid state.  Among the 
various approaches to improve solubility, the solid 
dispersion technique has often proved to be the most 
successful in improving the dissolution and 
bioavailability of poorly soluble drugs because it is 
simple, economic, and advantageous. [3] The term solid 
dispersion refers to a group of solid products consisting 
of at least two different components, a hydrophilic 
matrix and a hydrophobic drug. The drug can be 
dispersed molecularly, in amorphous particles (clusters) 
or in crystalline particles. Pharmaceutical polymers are 
used to create this matrix and their selection is based on 
many factors, including physicochemical (e.g. drug–
polymer miscibility and stability) and pharmacokinetic 
(e.g. rate of absorption) constraints. [4] 
 
ADVANTAGES OF SOLID DISPERSIONS 
1. To reduced particle size, 
2. For taste masking of the drug substance, 
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3. To obtain a homogenous distribution of small 
amount of drugs at solid state. 
4. To stabilize unstable drugs, 
5. To formulate sustained release dosage or prolonged 
release regimens of soluble drugs using poorly 
soluble or insoluble carriers.[5] 
 
DISADVANTAGES OF SOLID DISPERSION  
Although a great research interest is in solid dispersion 
in the past four decades, the commercial utilization is 
very limited. Problems of solid dispersion involve 
1. The physical and chemical stability of drugs and 
vehicles, 
2. Method of preparation, 
3. Reproducibility of its physicochemical properties, 
4. Formulation of solid dispersion into dosage forms, 
and 
5. Scale-up of manufacturing processes.[6] 
 
METHODS OF PREPARATION OF SOLID 
DISPERSIONS 
1. Melting method 
The melting or fusion method, involves the preparation 
of physical mixture of a drug and a water-soluble carrier 
and heating it directly until it melts. The melted mixture 
is then solidified rapidly in an ice-bath under vigorous 
stirring. The final solid mass is crushed, pulverized and 
sieved[5]. Appropriately this has undergone many 
modifications in pouring the homogenous melt in the 
form of a thin layer onto a ferrite plate or a stainless 
steel plate and cooled by flowing air or water on the 
opposite side of the plate. In addition, a super-saturation 
of a solute or drug in a system can often be obtained by 
quenching the melt rapidly from a high temperature. 
Under such conditions, the solute molecule is arrested in 
the solvent matrix by the instantaneous solidification 
process.[6] 
 
2. Solvent Evaporation  method 
 In this method, the physical mixture of the drug and 
carrier is dissolved in a common solvent, which is 
evaporated until a clear, solvent free film is left. The 
film is further dried to constant weight. The first step in 
the solvent method is the preparation of a solution 
containing both matrix material and drug [7]. The second 
step involves the removal of solvent(s) resulting in 
formation of a solid dispersion. Mixing at the molecular 
level is preferred, because this leads to optimal 
dissolution properties. The main advantage of the 
solvent method is thermal decomposition of drugs or 
carriers can be prevented because of the relatively low 
temperatures required for the evaporation of organic 
solvents. [8] 
 
Fig 1: Solvent Evaporation Technique 
 
3. Melting solvent method (melt evaporation) 
It involves preparation of solid dispersions by 
dissolving the drug in a suitable liquid solvent and then 
incorporating the solution directly into the melt of 
polyethylene glycol, which is then evaporated until a 
clear, solvent free film is left. The film is further dried 
to constant weight. The 5 –10% (w/w) of liquid 
compounds can be incorporated into polyethylene 
glycol6000 without significant loss of its solid 
property[9]. It is possible that the selected solvent or 
dissolved drug may not be miscible with the melt of the 
polyethylene glycol. Also the liquid solvent used may 
affect the polymorphic form of the drug, which 
precipitates as the solid dispersion. This technique 
possesses unique advantages of both the fusion and 
solvent evaporation methods. From a practical 
standpoint, it is only limited to drugs with a low 
therapeutic dose e.g. below 50 mg.[10] 
 
4. Melt extrusion method 
The drug/carrier mix is typically processed with a twin-
screw extruder. The drug/carrier mix is simultaneously 
melted, homogenized and then extruded and shaped as 
tablets, granules, pellets, sheets, sticks or powder. The 
intermediates can then be further processed into 
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conventional tablets. An important advantage of the hot 
melt extrusion method is that the drug/carrier mix is 
only subjected to an elevated temperature for about 1 
min, which enables drugs that are somewhat thermo 
labile to be processed.[11] 
 
5. Lyophilisation Technique 
Freeze-drying involves transfer of heat and mass to and 
from the product under preparation. This technique was 
proposed as an alternative technique to solvent 
evaporation. Lyophilisation has been thought of a 
molecular mixing technique where the drug and carrier 
are co dissolved in a common solvent, frozen and 
sublimed to obtain a lyophilized molecular dispersion. 
(Betageri GV et al). An important advantage of freeze 
drying is that the drug is subjected to minimal thermal 
stress during the formation of the solid dispersion. 
However, the most important advantage of freeze drying 
is that the risk of phase separation is minimized as soon 
as the solution is vitrified. An even more promising 
drying technique is spray-freeze drying. The solvent is 
sprayed into liquid nitrogen or cold dry air and the 
frozen droplets are subsequently lyophilized. The large 
surface area and direct contact with the cooling agent 
result in even faster vitrification, thereby decreasing the 
risk for phase separation to a minimum .Moreover, 
spray freeze drying offers the potential to customize the 
size of the particle to make them suitable for further 
processing or applications like pulmonary or nasal 
administration.[12] 
 
6. Melt Agglomeration Process 
This technique has been used to prepare SD wherein the 
binder acts as a carrier. In addition, SD(s) are prepared 
either by heating binder, drug and excipient to a 
temperature above the melting point of the binder (melt- 
in procedure) or by spraying a dispersion of drug in 
molten binder on the heated excipient (spray-on 
procedure) by using a high shear mixer. A rotary 
processor has been shown to be alternative equipment 
for melt agglomeration. The rotary processor might be 
preferable to the high melt agglomeration because it is 
easier to control the temperature and because a higher 
binder content can be incorporated in the agglomerates. 
The effect of binder type, method of manufacturing and 
particle size are critical parameters in preparation of 
SD(s) by melt agglomeration. Since these parameters 
result in variations in dissolution rates, mechanism of 
agglomerate formation and growth, agglomerate size, 
agglomerate size distribution and densification of 
agglomerates.  In addition the melt in procedure also 
results in homogenous distribution of drug in 
agglomerate. [13] 
 
7. The use of surfactant 
The utility of the surfactant systems in solubilization is 
well known. Adsorption of surfactant on solid surface 
can modify their hydrophobisity, surface charge, and 
other key properties that govern interfacial processes 
such as flocculation/dispersion, floatation, wetting, 
solubilization, detergency, enhanced oil recovery and 
corrosion inhibition[14]. Surfactants have also been 
reported to cause solvation/plasticization, manifesting in 
reduction of melting the active pharmaceutical 
ingredients, glass transition temperature and the 
combined glass transition temperature of solid 
dispersions. Because of these unique properties, 
surfactants have attracted the attention of investigators 
for preparation of solid dispersions.[15] 
 
8. Electrospinning 
Electrospinning is a process in which solid fibers are 
produced from a polymeric fluid stream solution or melt 
delivered through a millimeter-scale nozzle. This 
process involves the application of a strong electrostatic 
field over a conductive capillary attaching to a reservoir 
containing a polymer solution or melt and a conductive 
collection screen. Upon increasing the electrostatic field 
strength up to but not exceeding a critical value, charge 
species accumulated on the surface of a pendant drop 
destabilize the hemispherical shape into a conical shape 
(commonly known as Taylor s cone). Beyond the 
critical value, a charged polymer jet is ejected from the 
apex of the cone (as a way of relieving the charge built-
up on the surface of the pendant drop). The ejected 
charged jet is then carried to the collection screen via 
the electrostatic force. The Coulombic repulsion force is 
responsible for the thinning of the charged jet during its 
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trajectory to the collection screen. The thinning down of 
the charged jet is limited by the viscosity increase, as 
the charged jet is dried. This technique has tremendous 
potential for the preparation of nanofibres and 
controlling the release of biomedicine, as it is simplest, 
the cheapest this technique can be utilized for the 
preparation of solid dispersions in future.[16] 
 
9. Super Critical Fluid (SCF) Technology 
Supercritical fluid methods are mostly applied with 
carbon dioxide (CO2), which is used as either a solvent 
for drug and matrix or as an anti-solvent. When 
supercritical CO2 is used as solvent, matrix and drug are 
dissolved and sprayed through a nozzle, into an 
expansion vessel with lower pressure and particles are 
immediately formed. The adiabatic expansion of the 
mixture results in rapid cooling. This technique does not 
require the use of organic solvents and since CO2 is 
considered environmentally friendly, this technique is 
referred to as „solvent free‟. The technique is known as 
Rapid Expansion of Supercritical Solution (RESS). 
However, the application of this technique is very 
limited, because the solubility in CO2 of most 
pharmaceutical compounds is very low (<0.01wt- %) 
and decreases with increasing polarity. Therefore, 
scaling up this process to kilogram-scale will be 
impractical.[17] 
 
10. Direct capsule filling 
Direct filling of hard gelatin capsules with the liquid 
melt of solid dispersions avoids grinding-induced 
changes in the crystallinity of the drug. This molten 
dispersion forms a solid plug inside the capsule on 
cooling to room temperature, reducing cross 
contamination and operator exposure in a dust-free 
environment, better fill weight and content uniformity 
was obtained than with the powder-fill technique. 
However, PEG was not a suitable carrier for the direct 
capsule-filling method as the water-soluble carrier 
dissolved more rapidly than the drug, resulting in 
drugrich layers formed over the surface of dissolving 
plugs, which prevented further dissolution of the 
drug.[18] 
 
11. Dropping solution method 
The dropping method facilitate the crystallization of 
different chemicals and produces round particles from 
melted solid dispersions. In laboratory-scale 
preparation, a solid dispersion of a melted drug-carrier 
mixture is pipetted and then dropped onto a plate, where 
it solidifies into round particles. The size and shape of 
the particles can be influenced by factors such as the 
viscosity of the melt and the size of the pipette. Because 
viscosity is highly temperature-dependent, it is very 
important to adjust the temperature so that when the 
melt is dropped onto the plate it solidifies to a spherical 
shape. The use of carriers that solidify at room 
temperature may aid the dropping process. The 
dropping method not only simplifies the manufacturing 
process, but also gives a higher dissolution rate. It does 
not use organic solvents and, therefore, has none of the 
problems associated with solvent evaporation. The 
method also avoids the pulverization, sifting and 
compressibility difficulties encountered with the other 
melt methods. Disadvantages of the dropping method 
are that only thermo stable drugs can be used and the 
physical instability of solid dispersions is a further 
challenge.[19] 
 
12. Co-precipitation method 
Co-precipitation is a recognized technique for 
increasing the dissolution of poorly water soluble drugs, 
so as to consequently improve bioavailability. In this 
method nonsolvent is added drop wise to the drug and 
carrier solution, under constant stirring. In the course of 
the nonsolvent addition, the drug and carrier are co-
precipitated to form micro particles. At the end, the 
resulted micro particle suspension is filtered and dried. 
The required quantity of polymer and the drug were 
mixed and then solvent was added to obtain clear 
solution. The Solution was first dried under vacuum at 
room temperature and kept inside incubator (37°C) for 
12 hrs. Finally it was passed through sieves.[20] 
 
EVALUATION OF SOLID DISPERSION  
Estimation of drug content: A quantity (100mg) of 
solid dispersion is placed in a beaker containing 100 ml 
of Phosphate buffer (7.4). The dispersion was votexed 
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repeatedly to break up the solid dispersion and cause 
them to discharge their content completely. The solution 
is then filtered and analyzed spectrophotometrically 
using U V Spectrophotometry.[21] 
Drug Entrapment Efficiency (EE): The drug 
entrapment efficiency can be calculated by following 
formula- 
𝑬𝑬% =
𝐀𝐜𝐭𝐮𝐚𝐥 𝐝𝐫𝐮𝐠 𝐜𝐨𝐧𝐭𝐞𝐧𝐭    
𝐓𝐡𝐞𝐨𝐫𝐞𝐭𝐢𝐜𝐚𝐥 𝐝𝐫𝐮𝐠 𝐜𝐨𝐧𝐭𝐞𝐧𝐭
𝒙𝟏𝟎𝟎 
Particle Size Analysis and Morphological 
characteristics- It can be done by using Scanning 
Electron Microscopy. Samples from each batch is to be 
taken and dispersed in Phosphate Buffer (pH 7.4) .[22] 
Moisture Sorption Characteristics- Solid dispersion is 
placed in Petridish and stored in an activated desicating 
chamber at 10 degree C for one week to remove residual 
.[23] 
𝐄𝐪𝐮𝐢𝐥𝐢𝐛𝐫𝐢𝐮𝐦 𝐌𝐨𝐢𝐬𝐭𝐮𝐫𝐞 𝐒𝐨𝐫𝐩𝐭𝐢𝐨𝐧
=
𝐚𝐦𝐨𝐮𝐧𝐭 𝐨𝐟 𝐦𝐨𝐢𝐬𝐭𝐮𝐫𝐞 𝐬𝐨𝐫𝐩𝐞𝐝 𝐚𝐭 𝐞𝐪𝐮𝐢𝐥𝐢𝐛𝐫𝐢𝐮𝐦
𝐝𝐫𝐲 𝐰𝐞𝐢𝐠𝐡𝐭 𝐨𝐟 𝐦𝐚𝐭𝐞𝐫𝐢𝐚𝐥
 
In-vitro Drug Release Studies- The dissolution profile 
for each solid dispersion as well as pure diclofenac 
powder is performed using rotatory paddle containing 
dissolution medium and further spectrophotometry is 
done.[24] 
Stability Study of the formulation- is carried out on 
the best formulation and is packed in amber colored 
bottle, which is tightly plugged with cotton and capped 
with aluminium. [25] 
Differential Scanning Calorimetry (DSC) Frequently 
used technique to detect the amount of crystalline 
material is Differential Scanning Calorimetry (DSC). 
Samples are heated with a constant heating rate and the 
amount of energy necessary for that is detected. With 
DSC the temperatures at which thermal events occur 
can be detected. Thermal events can be a glass to rubber 
transition, recrystallization, melting or degradation. 
Furthermore, the melting & recrystallization energy can 
be quantified. The melting energy can be used to detect 
the amount of crystalline material.[26] 
 
CONCLUSIONS 
Since the concept of solid dispersion technology was 
introduced in 1960s, great progresses have been made in 
solid dispersion technology as solid dispersion offers a 
variety of opportunities. A single solid dispersion 
method cannot be universally accepted for a variety of 
drug materials. In developing a new solid dispersion 
system for a given drug, it is important to understand 
the physicochemical properties of the drug and carrier 
that best match the properties and find a solid dispersion 
method. The preparation method and the amount of the 
carrier also play a vital role in the enhancement of drug 
dissolution rate. Most of the solid dispersion work is in 
lab-scale setups; therefore the manufacturing process 
requires enough knowledge to scale up to the 
commercial scale. 
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